TaleNeprilysin and Neprilysin inhibition in chronic kidney disease

TaleNeprilysin and Neprilysin inhibition in chronic kidney disease

<p><strong>Purpose of review </strong></p> Chronic kidney disease (CKD) is associated with increased risk of progression to end-stage kidney disease and cardiovascular events. There is limited evidence that available treatments have beneficial effects on cardiorenal outcomes...

書誌詳細
主要な著者:	Judge, PK, Haynes, R
フォーマット:	Journal article
言語:	English
出版事項:	Lippincott, Williams & Wilkins 2021

類似資料

Neprilysin inhibition in chronic kidney disease.
著者:: Judge, P, 等
出版事項: (2014)

Chronic kidney disease, heart failure and neprilysin inhibition
著者:: Haynes, R, 等
出版事項: (2019)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
著者:: Kawa Dizaye, 等
出版事項: (2019-05-01)

Neprilysin Inhibitors and Bradykinin
著者:: Duncan J. Campbell, 等
出版事項: (2018-09-01)

2003 Mixed meal effects of neprilysin inhibition
著者:: Jessica R. Wilson, 等
出版事項: (2018-06-01)

Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
著者:: Erika Hishida, 等
出版事項: (2024-10-01)

Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease
著者:: In-Jeong Cho, 等
出版事項: (2021-12-01)

Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen.
著者:: Matthew Burrell, 等
出版事項: (2016-01-01)

Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice
著者:: Nathalie Esser, 等
出版事項: (2022-06-01)

Application of Angiotensin Receptor–Neprilysin Inhibitor in Chronic Kidney Disease Patients: Chinese Expert Consensus
著者:: Liangying Gan, 等
出版事項: (2022-07-01)

Neprilysin as a Biomarker: Challenges and Opportunities
著者:: Noemi Pavo, 等
出版事項: (2020-08-01)

Relevance of Neutrophil Neprilysin in Heart Failure
著者:: Suriya Prausmüller, 等
出版事項: (2021-10-01)

Urinary neprilysin in the critically ill patient
著者:: Sahra Pajenda, 等
出版事項: (2017-05-01)

The role of neprilysin in regulating the hair cycle.
著者:: Naoko Morisaki, 等
出版事項: (2013-01-01)

Serum neprilysin levels are elevated in preeclampsia
著者:: Nevin Tüten, 等
出版事項: (2021-09-01)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
著者:: Hitoshi Nakagawa, 等
出版事項: (2022-07-01)

Urinary neprilysin – Another marker to predict postoperative acute kidney injury
著者:: Abhijit Nair, 等
出版事項: (2023-01-01)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
著者:: A.S. Ryazanov, 等
出版事項: (2023-04-01)

Soluble neprilysin and survival in critically ill patients
著者:: Max Lenz, 等
出版事項: (2022-04-01)

Getting the “Right” Perspective on Angiotensin Receptor–Neprilysin Inhibition in Heart Failure
著者:: Frederik H. Verbrugge, 等
出版事項: (2020-07-01)

Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
著者:: Sverre E. Kjeldsen, 等
出版事項: (2019-03-01)

Angiotensin Receptor‐Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension
著者:: Danial Sharifi Kia, 等
出版事項: (2020-07-01)

Breakthrough in Heart Failure therapy: LCZ696 combining ACE-Neprilysin inhibition
著者:: Sandeep Lahiry
出版事項: (2017-01-01)

Adipolin, Chemerin, Neprilysin and Metabolic Disorders Associated with Obesity
著者:: Marcelina Sperling, 等
出版事項: (2023-07-01)

Active site mutations change the cleavage specificity of neprilysin.
著者:: Travis Sexton, 等
出版事項: (2012-01-01)

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure
著者:: Julio Núñez, 等
出版事項: (2017-08-01)

Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats
著者:: Iuliia Polina, 等
出版事項: (2021-01-01)

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
著者:: Suriya Prausmüller, 等
出版事項: (2020-06-01)

The Association between Neprilysin gene polymorphisms and Alzheimer’s disease in Tibetan population
著者:: Siwei Chen, 等
出版事項: (2021-03-01)

Brain Shuttle Neprilysin reduces central Amyloid-β levels.
著者:: Christopher R Campos, 等
出版事項: (2020-01-01)

Elevated neprilysin in placental vesicles derived from preeclamptic pregnancies
著者:: Gill, M, 等
出版事項: (2018)

The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia‐reperfusion injury in the rat
著者:: Fayez T. Hammad, 等
出版事項: (2021-03-01)

Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease
著者:: Yogesh N. V. Reddy, 等
出版事項: (2019-08-01)

Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
著者:: Roda Plakogiannis, 等
出版事項: (2025-02-01)

Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion
著者:: Kangbo Li, 等
出版事項: (2023-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
著者:: Miners, J, 等
出版事項: (2006)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
著者:: Robert eMarr, 等
出版事項: (2014-08-01)

Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.
著者:: Carl I Webster, 等
出版事項: (2014-01-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
著者:: Rolf Wachter, 等
出版事項: (2020-06-01)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
著者:: Shunichiro Tsukamoto, 等
出版事項: (2023-04-01)